These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18297444)

  • 1. The antagonistic effects of a combination of vancomycin and minocycline in Staphylococcus aureus with heterogeneous resistance to vancomycin.
    Oshiro T; Nagasawa Z; Hanaki H; Ikeda-Dantsuji Y; Nagayama A
    J Infect Chemother; 2008 Feb; 14(1):15-22. PubMed ID: 18297444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiological investigation of "beta-lactam antibiotic induced vancomycin-resistant MRSA (BIVR)"].
    Hanaki H; Yamaguchi Y
    Kansenshogaku Zasshi; 2003 Jul; 77(7):499-504. PubMed ID: 12931576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined effect of vancomycin or teicoplanin plus a beta-lactam antibiotic in mouse infection models caused by beta-lactam antibiotec-induced vancomycin resistant MRSA (BIVR)].
    Hatano K; Yokota Y; Hanaki H; Sunakawa K
    Kansenshogaku Zasshi; 2006 May; 80(3):243-50. PubMed ID: 16780131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration.
    Yamaguchi Y; Hanaki H; Yanagisawa C; Ikeda-Dantsuji Y; Hashimoto T; Yazaki H; Sugahara K; Yanagisawa T; Kawajiri H; Sato S; Ishizaki A; Tachihara-Sato R; Takahashi Y; Ono T; Kageyama Y; Kawaguchi T; Tamura A; Hagane K; Sunakawa K
    J Infect Chemother; 2009 Oct; 15(5):274-8. PubMed ID: 19856063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination effect of pazufloxacin and anti-mrsa drugs against beta-lactam antibiotic induced vancomycin-resistant MRSA (BIVR)].
    Yanagisawa C; Hanaki H; Oishi T; Uehara K; Yamaguchi Y; Matui H; Sunakawa K
    Jpn J Antibiot; 2005 Feb; 58(1):11-6. PubMed ID: 15847221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and genomic comparisons of highly vancomycin-resistant Staphylococcus aureus strains developed from multiple clinical MRSA strains by in vitro mutagenesis.
    Ishii K; Tabuchi F; Matsuo M; Tatsuno K; Sato T; Okazaki M; Hamamoto H; Matsumoto Y; Kaito C; Aoyagi T; Hiramatsu K; Kaku M; Moriya K; Sekimizu K
    Sci Rep; 2015 Nov; 5():17092. PubMed ID: 26603341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus].
    Fukuoka T; Domon H; Kakuta M; Ishii C; Hirasawa A; Utsui Y; Ohya S; Yasuda H
    Jpn J Antibiot; 1997 Apr; 50(4):411-9. PubMed ID: 9192249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of rapid antimicrobial susceptibility test for Staphylococcus aureus by chemiluminescent assay and its application for screening of beta-lactam antibiotic induced vancomycin-resistant MRSA].
    Nagasawa Z; Nakashima Y; Oho M; Kusaba K; Manome I; Nagayama A
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2008; 19(1-2):7-15. PubMed ID: 19583457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nosocomial infection of beta-lactam antibiotic-induced vancomycin-resistant Staphylococcus aureus (BIVR).
    Hososaka Y; Hanaki H; Yanagisawa C; Yamaguchi Y; Matsui H; Nakae T; Iwata S; Hayashi I; Sunakawa K
    J Infect Chemother; 2006 Aug; 12(4):181-4. PubMed ID: 16944255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Method of detecting beta-lactam antibiotic induced vancomycin resistant MRSA (BIVR).
    Hanaki H; Yamaguchi Y; Nomura S; Haraga I; Nagayama A; Sunakawa K
    Int J Antimicrob Agents; 2004 Jan; 23(1):1-5. PubMed ID: 14732306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection.
    Takata T; Miyazaki M; Futo M; Hara S; Shiotsuka S; Kamimura H; Yoshimura H; Matsunaga A; Nishida T; Ishikura H; Ishikawa T; Tamura K; Tsuji BT
    Scand J Infect Dis; 2013 Mar; 45(3):203-12. PubMed ID: 23113753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field.
    Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J
    Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiological investigation of MRSA with antagonistic effects of beta-lactam antibiotic and vancomycin].
    Yamaguchi Y; Hanaki H; Barada K; Inamatu T; Sunakawa K
    Kansenshogaku Zasshi; 2003 Sep; 77(9):661-6. PubMed ID: 14574841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of vancomycin resistance during therapy against methicillin-resistant Staphylococcus aureus in a burn patient--importance of low-level resistance to vancomycin.
    Haraga I; Nomura S; Fukamachi S; Ohjimi H; Hanaki H; Hiramatsu K; Nagayama A
    Int J Infect Dis; 2002 Dec; 6(4):302-8. PubMed ID: 12718825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacteriological evaluation of combined effects of vancomycin and beta-lactams. I. Results against methicillin-resistant Staphylococcus aureus].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1993 Nov; 46(11):939-45. PubMed ID: 8309069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR).
    Hanaki H; Yamaguchi Y; Yanagisawa C; Uehara K; Matsui H; Yamaguchi Y; Hososaka Y; Barada K; Sakai F; Itabashi Y; Ikeda S; Atsuda K; Tanaka H; Inamatsu T; Nagayama A; Sunakawa K
    J Infect Chemother; 2005 Apr; 11(2):104-6. PubMed ID: 15856381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical studies on vancomycin in the treatment of MRSA infection].
    Shimizu K; Orizu M; Kanno H; Kitamura S; Konishi T; Soma K; Nishitani H; Noguchi Y; Hasegawa S; Hasegawa H; Wada K
    Jpn J Antibiot; 1996 Aug; 49(8):782-99. PubMed ID: 9053533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiological investigation of beta-lactam antibiotic induced vancomycin-resistant MRSA from clinical isolated MRSA--comparison of detection rate of BIVR with or without CZX].
    Hososaka Y; Hanaki H; Hayashi I; Kamibeppu K; Sunakawa K
    Kansenshogaku Zasshi; 2004 Aug; 78(8):717-21. PubMed ID: 15478647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycin.
    Nakazawa H; Kikuchi Y; Honda T; Isago T; Nozaki M
    J Infect Chemother; 2003 Dec; 9(4):304-9. PubMed ID: 14691650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus.
    Toyokawa M; Asari S; Nishi I; Horikawa M; Tsukamoto H; Sunada A; Ueda A; Iwatani Y
    J Chemother; 2003 Feb; 15(1):31-6. PubMed ID: 12678411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.